TFF2 and cancer: With few exceptions, lncRNA/miRNA pathways that lead to higher expression of Sp1, Sp3 and Sp4 result in downstream activation of pro-oncogenic genes/pathways, indicating that drugs targeting ncRNAs or Sp TFs should be highly effective anti-cancer agents.